Immune mechanisms in atherosclerosis.

Atherosclerosis is an inflammatory disease. Its lesions are filled with immune cells that can orchestrate and effect inflammatory responses. In fact, the first lesions of atherosclerosis consist of macrophages and T cells. Unstable plaques are particularly rich in activated immune cells, suggesting that they may initiate plaque activation. We have seen a rapid increase in the understanding of the mechanisms that govern the recruitment, differentiation, and activation of immune cells in atherosclerosis. Experimental research has identified several candidate antigens, and there are encouraging data suggesting that immune modulation as well as immunization can reduce the progression of the disease. This review provides an overview of our current understanding of the role of immune mechanisms in atherosclerosis. (Arterioscler Thromb Vasc Biol. 2001;21:1876-1890.)

[1]  G. Hansson,et al.  Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[2]  C. Vedeler,et al.  In situ characterization of the foam cells in early human atherosclerotic lesions. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.

[3]  P. Kovanen,et al.  Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. , 1996, Circulation.

[4]  J. Nilsson,et al.  Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL , 1996 .

[5]  J. Peschon,et al.  Accelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55* , 1996, The Journal of Biological Chemistry.

[6]  F. Aoudjit,et al.  Interleukin-4, transforming growth factor beta 1, and dexamethasone inhibit superantigen-induced prostaglandin E2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[7]  P. Sorlie,et al.  Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. , 1996, Circulation.

[8]  Charles R. Mackay.  Chemokine receptors and T cell chemotaxis , 1996, The Journal of experimental medicine.

[9]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[10]  M. Leon,et al.  Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. , 1996, The New England journal of medicine.

[11]  R. Silverstein,et al.  Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[12]  J. Witztum,et al.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. , 1996, The Journal of clinical investigation.

[13]  R. Terkeltaub,et al.  Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. , 1996, The Journal of clinical investigation.

[14]  P. Shah,et al.  Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M L Woods,et al.  Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. , 1996, Journal of the American College of Cardiology.

[16]  L. Demer,et al.  Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. , 1996, The Journal of clinical investigation.

[17]  P. Lachmann,et al.  Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[18]  T. Quinn,et al.  Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. , 1996, The Journal of infectious diseases.

[19]  R. Kiessling,et al.  Induction of heat shock protein in monocytic cells by oxidized low density lipoprotein. , 1996, Atherosclerosis.

[20]  J. Mudgett,et al.  Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Goetzl,et al.  Matrix metalloproteinases in immunity. , 1996, Journal of immunology.

[22]  F. Lang,et al.  Mononuclear leukocytes invade rabbit arterial intima during thickening formation via CD18-and VLA-4-dependent mechanisms and stimulate smooth muscle migration. , 1995, Circulation research.

[23]  S. Studenski,et al.  Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. , 1995, Arthritis and rheumatism.

[24]  L. Yeatman,et al.  Effect of pravastatin on outcomes after cardiac transplantation. , 1995, The New England journal of medicine.

[25]  P. Constantinides.  Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. , 1995, Circulation.

[26]  Michael Ginsberg,et al.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Y. Bobryshev,et al.  Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta. , 1995, Archives of histology and cytology.

[28]  T. Eberlein,et al.  T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Maniatis,et al.  Transcriptional regulation of endothelial cell adhesion molecules: NF‐κB and cytokine‐inducible enhancers , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[31]  D. Collen,et al.  Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. , 1995, The Journal of clinical investigation.

[32]  H. Sasano,et al.  Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Pober,et al.  CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Y. Bobryshev,et al.  S-100 positive cells in human arterial intima and in atherosclerotic lesions. , 1995, Cardiovascular research.

[35]  U. de Faire,et al.  Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[36]  B. Risberg,et al.  Interferon-γ modulates the fibrinolytic response in cultured human endothelial cells , 1995 .

[37]  T. Lint,et al.  Structure and function of the pentraxins. , 1995, Current opinion in immunology.

[38]  J. Berliner,et al.  Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. , 1995, The Journal of clinical investigation.

[39]  E. Miller,et al.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Morrow,et al.  Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. , 1994, The Journal of biological chemistry.

[41]  R. Roubey.  Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. , 1994, Blood.

[42]  P. Kovanen,et al.  Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. , 1994, Circulation.

[43]  S. Schwartz,et al.  Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[44]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[45]  P. Kovanen,et al.  Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. , 1994, The Journal of biological chemistry.

[46]  V. Ord,et al.  ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[47]  H. Niiro,et al.  IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. , 1994, International immunology.

[48]  Y. Vodovotz,et al.  Mechanism of suppression of nitric oxide synthase expression by interleukin‐4 in primary mouse macrophages , 1994, Journal of leukocyte biology.

[49]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[50]  A. Gown,et al.  Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[51]  C. Alpers,et al.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.

[52]  G. Hughes.  The antiphospholipid syndrome: ten years on , 1993, The Lancet.

[53]  K. Messmer,et al.  Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[54]  P. Libby,et al.  An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[55]  Qingbo Xu,et al.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.

[56]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Cybulsky,et al.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.

[58]  A. Gown,et al.  Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[59]  O. Nived,et al.  Cardiovascular Disease in Systemic Lupus Erythematosus A Study of 75 Patients from a Defined Population , 1992, Medicine.

[60]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[61]  R. Giscombe,et al.  Induction of T-cell activation by oxidized low density lipoprotein. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[62]  U. Ikeda,et al.  Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits. , 1992, Atherosclerosis.

[63]  G. Hansson,et al.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[64]  A. Fogelman,et al.  Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha. , 1992, Journal of immunology.

[65]  G. Hansson,et al.  Polyclonal origin of T lymphocytes in human atherosclerotic plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[66]  M. Gidlund,et al.  Biologically modified LDL increases the adhesive properties of endothelial cells. , 1991, Atherosclerosis.

[67]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[68]  P. Libby,et al.  Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[69]  G. Hansson,et al.  Interferon‐γ Inhibits Arterial Stenosis After Injury , 1991 .

[70]  D. Steinberg,et al.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[71]  L. Klareskog,et al.  Role of hsp60 during Autoimmune and Bacterial Inflammation , 1991, Immunological reviews.

[72]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[73]  S. Bhakdi,et al.  Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions , 1990, The Journal of experimental medicine.

[74]  S. Ylä-Herttuala,et al.  Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.

[75]  D. Brown,et al.  Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. , 1990, Archives of pathology & laboratory medicine.

[76]  P. Libby,et al.  Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. , 1990, The Journal of clinical investigation.

[77]  A. Hamsten,et al.  Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Fishbein,et al.  Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.

[79]  A. Becker,et al.  Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[80]  T. Rector,et al.  Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. , 1989, The American journal of cardiology.

[81]  G. Hansson,et al.  Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. , 1989, The Journal of clinical investigation.

[82]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.

[83]  G. Hansson,et al.  Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[84]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[85]  S. Dower,et al.  Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. , 1989, Science.

[86]  P. Libby,et al.  Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. , 1989, Journal of immunology.

[87]  J. Oram,et al.  Up-regulation of high density lipoprotein receptor activity by gamma-interferon associated with inhibition of cell proliferation. , 1988, The Journal of biological chemistry.

[88]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[89]  M. Kazatchkine,et al.  The complement system in atherosclerosis. , 1988, Atherosclerosis.

[90]  M. Lopes-Virella,et al.  Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation , 1988, The Journal of experimental medicine.

[91]  Mark M. Davis,et al.  T-cell antigen receptor genes and T-cell recognition , 1988, Nature.

[92]  O. Kocher,et al.  Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. , 1988, Atherosclerosis.

[93]  R. Jonsson,et al.  HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis. , 1988, Clinical and experimental immunology.

[94]  C. Heldin,et al.  INDUCTION OF B-TYPE RECEPTORS FOR PLATELET-DERIVED GROWTH FACTOR IN VASCULAR INFLAMMATION: POSSIBLE IMPLICATIONS FOR DEVELOPMENT OF VASCULAR PROLIFERATIVE LESIONS , 1988, The Lancet.

[95]  M. Brenner.  Leucocyte Typing III. White Cell Differentiation Antigens , 1988 .

[96]  G. Hansson,et al.  Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[97]  W. Fiers,et al.  Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons , 1988, The Journal of experimental medicine.

[98]  L. Jonasson,et al.  Smooth muscle cells express Ia antigens during arterial response to injury. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[99]  P. Libby,et al.  Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. , 1988, The Journal of clinical investigation.

[100]  S. Enerbäck,et al.  Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor. , 1988, The Biochemical journal.

[101]  E. Emeson,et al.  T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. , 1988, The American journal of pathology.

[102]  R. Cotran,et al.  Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[103]  P. Libby,et al.  Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. , 1987, Journal of immunology.

[104]  Y. Saegusa,et al.  Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. , 1987, Journal of immunology.

[105]  J L Witztum,et al.  Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits. , 1987, Journal of lipid research.

[106]  A. Bengtsson,et al.  IgG binding to cytoskeletal intermediate filaments activates the complement cascade. , 1987, Experimental cell research.

[107]  G. Bondjers,et al.  Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages. , 1987, Journal of lipid research.

[108]  Randall,et al.  Gamma-interferon inhibits collagen synthesis in vivo in the mouse. , 1987, The Journal of clinical investigation.

[109]  J. D. van der Walt,et al.  An immunohistochemical analysis of human aortic fatty streaks. , 1987, Human pathology.

[110]  P. Scheurich,et al.  Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. , 1987, Journal of immunology.

[111]  J. Vilček,et al.  A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1 , 1987, Molecular and cellular biology.

[112]  N. Cerf-Bensussan,et al.  Increased HLA-DR expression by enterocytes in children with celiac disease. , 1986, Gastroenterology.

[113]  A. Gown,et al.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.

[114]  D. Glass,et al.  Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation. , 1986, The Journal of clinical investigation.

[115]  D. Parums,et al.  The localisation of immunoglobulin in chronic periaortitis. , 1986, Atherosclerosis.

[116]  P. Libby,et al.  Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.

[117]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[118]  R. Geha,et al.  Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. , 1986, The Journal of clinical investigation.

[119]  L. Jonasson,et al.  Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. , 1986, Clinical and experimental immunology.

[120]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[121]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[122]  K. Britten,et al.  Inflammatory infiltrates in human coronary atherosclerosis. , 1986, Atherosclerosis.

[123]  W. Fiers,et al.  Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. , 1986, Journal of immunology.

[124]  J. Annand.  Denatured bovine immunoglobulin pathogenic in atherosclerosis. , 1986, Atherosclerosis.

[125]  N. Alexander,et al.  Diet and vasectomy: effects on atherogenesis in cynomolgus macaques. , 1986, Experimental and molecular pathology.

[126]  P. Libby,et al.  Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. , 1986, Transplantation.

[127]  A. Hamsten,et al.  ANTIBODIES TO CARDIOLIPIN IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION: AN ASSOCIATION WITH RECURRENT CARDIOVASCULAR EVENTS , 1986, The Lancet.

[128]  B. Beutler,et al.  Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. , 1985, Journal of immunology.

[129]  B. Beutler,et al.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. , 1985, Journal of immunology.

[130]  R. Ross,et al.  A significant part of macrophage-derived growth factor consists of at least two forms of PDGF , 1985, Cell.

[131]  R. Cotran,et al.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.

[132]  H. Rus,et al.  Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. , 1985, Atherosclerosis.

[133]  P. Needleman,et al.  Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. , 1985, Journal of immunology.

[134]  L. Brasile,et al.  Role of the Vascular Endothelial Cell Antigen System In the Etiology of Atherosclerosis , 1985, Annals of surgery.

[135]  S. Krane,et al.  Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. , 1985, The Journal of clinical investigation.

[136]  G. Gabbiani,et al.  Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. , 1985, The Journal of clinical investigation.

[137]  H. Waldmann,et al.  Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies , 1985, The Journal of pathology.

[138]  B. Beutler,et al.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.

[139]  D. Klurfeld,et al.  Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. , 1985, Archives of pathology & laboratory medicine.

[140]  L. Orci,et al.  Human endothelial cell cultures: Phenotypic modulation by leukocyte interleukins , 1985, Journal of cellular physiology.

[141]  J. Lamb,et al.  Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells , 1984, Nature.

[142]  H. Waldmann,et al.  Monocytic origin of foam cells in human atherosclerotic plaques. , 1984, Atherosclerosis.

[143]  C. Reinisch,et al.  The role of vascular smooth muscle cells in experimental autoimmune vasculitis. I. The initiation of delayed type hypersensitivity angiitis. , 1984, The American journal of pathology.

[144]  S. Schwartz,et al.  Expression of the sis gene by endothelial cells in culture and in vivo. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[145]  H. Weiner,et al.  Lyt-1 cells mediate acute murine experimental allergic encephalomyelitis. , 1984, Journal of immunology.

[146]  H. Wekerle.  The lesion of acute experimental autoimmune encephalomyelitis. Isolation and membrane phenotypes of perivascular infiltrates from encephalitic rat brain white matter. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[147]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation , 1984, Arteriosclerosis.

[148]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: II. Fatty Streak Conversion to Fibrous Plaque , 1984, Arteriosclerosis.

[149]  E. Hjelm.  Local cellular immune response in ascending urinary tract infection: occurrence of T-cells, immunoglobulin-producing cells, and Ia-expressing cells in rat urinary tract tissue , 1984, Infection and immunity.

[150]  S. Schwartz,et al.  Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[151]  E. Unanue,et al.  Antigen presentation: comments on its regulation and mechanism. , 1984, Journal of immunology.

[152]  D. Doniach,et al.  ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY , 1983, The Lancet.

[153]  W. Fiers,et al.  Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon , 1983, Nature.

[154]  J. McDougall,et al.  Viruses in the etiology of atherosclerosis. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[155]  E. Maccarthy,et al.  Human mononuclear cell modulation of endothelial cell proliferation. , 1983, The Journal of laboratory and clinical medicine.

[156]  S. Schwartz,et al.  Evidence for cell death in the vascular endothelium in vivo and in vitro. , 1983, The American journal of pathology.

[157]  A. Orekhov,et al.  Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[158]  D. Mason,et al.  Induction of Ia antigen in rat epidermal cells and gut epithelium by immunological stimuli , 1982, The Journal of experimental medicine.

[159]  L. Klareskog,et al.  Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[160]  D. Steinberg,et al.  Lipoprotein lipase secretion by human monocytes and rabbit alveolar macrophages in culture. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[161]  G. Bondjers,et al.  Fc-dependent binding of monocytes to areas with endothelial injury in the rabbit aorta. , 1981, Experimental and molecular pathology.

[162]  R. Gerrity,et al.  The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. , 1981, The American journal of pathology.

[163]  L. Hansson,et al.  IMMUNOLOGICAL CHANGES IN PATIENTS WITH PREVIOUS MALIGNANT ESSENTIAL HYPERTENSION , 1981, The Lancet.

[164]  S. Glagov,et al.  Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. , 1980, The American journal of pathology.

[165]  P. Edwards,et al.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[166]  M. Dallman,et al.  Immunisation against heterologous type II collagen induces arthritis in mice , 1980, Nature.

[167]  W. Hollander,et al.  Soluble proteins in the human atheroschlerotic plaque , 1979 .

[168]  H. Shio,et al.  Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[169]  A. Pang,et al.  C3 deposition in cholesterol-induced atherosclerosis in rabbits: a possible etiologic role for complement in atherogenesis. , 1979, Journal of immunology.

[170]  C. Minick,et al.  Atheroarteriosclerosis induced by infection with a herpesvirus. , 1979, The American journal of pathology.

[171]  V. Lehto,et al.  Activation of complement by cytoskeletal intermediate filaments , 1979, Nature.

[172]  G. Bondjers,et al.  Plasma protein accumulation in injured endothelial cells. Immunofluorescent localization of IgG and fibrinogen in the rabbit aortic endothelium. , 1979, Experimental and molecular pathology.

[173]  T. Edgington,et al.  Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein. , 1978, The Journal of clinical investigation.

[174]  D. Alonso,et al.  Role of Immunologic Arterial Injury in Atherogenesis , 1978, Thrombosis and Haemostasis.

[175]  K. Ho,et al.  Cholesterol dynamics in autoimmune hyperlipidemia. , 1976, The Journal of laboratory and clinical medicine.

[176]  O. B. Bayliss,et al.  Detection of macrophages in atherosclerotic lesions with cytochrome oxidase. , 1976, British journal of experimental pathology.

[177]  M. Schotz,et al.  Detection and partial characterization of lipoprotein lipase in bovine aorta. , 1975, Biochimica et biophysica acta.

[178]  H. Müller-Eberhard,et al.  Neoantigens of the membrane attack complex of human complement. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[179]  Minick Cr,et al.  Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. II. Effect of repeatedly injected foreign protein in rabbits fed a lipid-rich, cholesterol-poor diet. , 1973, The American journal of pathology.

[180]  H. Rowsell,et al.  Deposition of formed elements of blood on the intima and signs of intimal injury in the aorta of rabbit, pig, and man. , 1972, Laboratory investigation; a journal of technical methods and pathology.

[181]  H. Kodama,et al.  Plane xanthomatosis with antilipoprotein autoantibody. , 1972, Archives of dermatology.

[182]  Roberto Iotti,et al.  [Causes of death in systemic lupus erythematosus]. , 1970, Prensa medica argentina.

[183]  W. Still,et al.  COMPARATIVE MORPHOLOGY OF THE EARLY ATHEROSCLEROTIC LESION IN MAN AND CHOLESTEROL-ATHEROSCLEROSIS IN THE RABBIT AN ELECTRONMICROSCOPIC STUDY. , 1964, Journal of atherosclerosis research.

[184]  C. J. Schwartz,et al.  Cellular Infiltration of the Human Arterial Adventitia Associated with Atheromatous Plaques , 1962, Circulation.

[185]  J. Strong,et al.  The fine structure of human atherosclerotic lesions. , 1961, The American journal of pathology.

[186]  H. Florey,et al.  Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits. , 1958, The Journal of pathology and bacteriology.

[187]  Arterioscler Thromb,et al.  Arteriosclerosis , 1925, Steinkopff.

[188]  P. Libby,et al.  Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β , 1996 .

[189]  R. Mariuzza,et al.  The structure of the T cell antigen receptor. , 1996, Annual review of immunology.

[190]  P. Libby,et al.  Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells. , 1996, Circulation research.

[191]  G. Wick,et al.  Coexpression of heat-shock protein 60 and intercellular-adhesion molecule-1 is related to increased adhesion of monocytes and T cells to aortic endothelium of rats in response to endotoxin. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[192]  Qingbo Xu,et al.  Is atherosclerosis an immunologically mediated disease? , 1995, Immunology today.

[193]  B L Langille,et al.  Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[194]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[195]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[196]  R. Loire,et al.  Coronary artery lesions and human immunodeficiency virus infection. , 1993, Research in virology.

[197]  P. Kovanen,et al.  Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis. , 1992, Journal of lipid research.

[198]  H. Kuhn,et al.  Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[199]  M. V. van Dam-Mieras,et al.  The possible role of cytomegalovirus in atherogenesis. , 1991, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[200]  M. Hemler.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes. , 1990, Annual review of immunology.

[201]  C. V. van Boven,et al.  High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. , 1990, The American journal of pathology.

[202]  H Suzuki,et al.  Interferon-gamma modulates messenger RNA levels of c-sis (PDGF-B chain), PDGF-A chain, and IL-1 beta genes in human vascular endothelial cells. , 1989, The American journal of pathology.

[203]  T. Carew,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[204]  B. Beutler,et al.  The role of cachectin/TNF in endotoxic shock and cachexia. , 1988, Immunology today.

[205]  R. Jonsson,et al.  Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[206]  N. Parfrey,et al.  Role of T helper lymphocytes in autoimmune diseases. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[207]  M. Hemler,et al.  Adhesive protein receptors on hematopoietic cells. , 1988, Immunology today.

[208]  A. Gown,et al.  Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. , 1987, Arteriosclerosis.

[209]  W. Fiers,et al.  Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[210]  L. Klareskog,et al.  Homologous type II collagen induces chronic and progressive arthritis in mice. , 1986, Arthritis and rheumatism.

[211]  H. Rus,et al.  Localization of the terminal C5b-9 complement complex in the human aortic atherosclerotic wall. , 1985, Immunology letters.

[212]  J. Oppenheim.  Antigen nonspecific lymphokines: an overview. , 1985, Methods in enzymology.

[213]  R. Gerrity.  The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981, The American journal of pathology.

[214]  P. Nilsson-ehle,et al.  Lipolytic enzymes and plasma lipoprotein metabolism. , 1980, Annual review of biochemistry.

[215]  N. Alexander,et al.  Long-term vasectomy: effects on the occurrence and extent of atherosclerosis in rhesus monkeys. , 1980, The Journal of clinical investigation.

[216]  J. C. Geer.  Fine structure of human aortic intimal thickening and fatty streaks. , 1965, Laboratory investigation; a journal of technical methods and pathology.